Hematology-Oncology Associates of the Quad-Cities, PC
Liver Cancer Trials
CALGB 80802: A Phase III Randomized Study of sorafenib plus doxorubicin vs sorafenib in patients with advanced hepatocellular carcinoma (HCC).
hematology_oncology_site001008.gif
Home
hematology_oncology_site001008.gif
Providers
Clinical Trials
hematology_oncology_site001008.gif
Services
Patient Info
hematology_oncology_site001008.gif
Links
Directions
hematology_oncology_site001008.gif
Contact Info